MARKET

NYXH

NYXH

NYXOAH S A
NASDAQ
1.545
+0.045
+3.00%
Opening 11:07 09/11 EDT
OPEN
1.540
PREV CLOSE
1.500
HIGH
1.550
LOW
1.530
VOLUME
35.78K
TURNOVER
--
52 WEEK HIGH
6.87
52 WEEK LOW
1.260
MARKET CAP
154.61M
P/E (TTM)
-0.6254
1D
5D
1M
3M
1Y
5Y
1D
Reported Earlier, Nyxoah Begins US Study Of Sleep Apnea Implant In First Patient
Benzinga · 3d ago
Nyxoah Launches Major U.S. Post-Approval Study for Genio Sleep Apnea Device
TipRanks · 4d ago
Nyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio® System
Barchart · 4d ago
Weekly Report: what happened at NYXH last week (0831-0904)?
Weekly Report · 4d ago
Nyxoah rises as trial win for Genio boosts case for label expansion
Seeking Alpha · 09/03 18:25
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 09/03 12:05
Nyxoah's ACCCESS Trial Of Genio System Meets Primary Goals In CCC Sleep Apnea Patients; Shares Jump
NASDAQ · 09/03 05:34
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 09/02 21:06
More
About NYXH
Nyxoah SA is a Belgium-based company that produces medical equipment. The company focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.

Webull offers Nyxoah SA stock information, including NASDAQ: NYXH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NYXH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NYXH stock methods without spending real money on the virtual paper trading platform.